Home › Papillary Thyroid Cancer › California
Papillary Thyroid Cancer clinical trials in California
3 studies for Papillary Thyroid Cancer are looking for participants at sites in California.
XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
- Harbor-UCLA Medical Center, Torrance
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT06959641Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
- City of Hope Medical Center, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 2, 2026 · NCT06440850Targeted Therapy to Increase RAI Uptake in Metastatic DTC
- University of California San Francisco, San Francisco
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT05024929From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.